Tumor necrosis factor-α predicts response to cardiac resynchronization therapy in patients with chronic heart failure.
Rordorf R, Savastano S, Sanzo A, Spazzolini C, De Amici M, Camporotondo R, Ghio S, Vicentini A, Petracci B, De Regibus V, Taravelli E, Landolina M, Schwartz PJ.
Rordorf R, et al. Among authors: savastano s.
Circ J. 2014;78(9):2232-9. doi: 10.1253/circj.cj-14-0023. Epub 2014 Jun 20.
Circ J. 2014.
PMID: 24954238
Free article.
Clinical Trial.